These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23245688)

  • 41. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
    Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
    Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
    Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T
    Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma.
    Darwish OM; Kapur P; Youssef RF; Bagrodia A; Belsante M; Alhalabi F; Sagalowsky AI; Lotan Y; Margulis V
    Urology; 2013 Mar; 81(3):581-6. PubMed ID: 23290145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
    Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
    Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma.
    Karamchandani JR; Gabril MY; Ibrahim R; Scorilas A; Filter E; Finelli A; Lee JY; Ordon M; Pasic M; Romaschin AD; Yousef GM
    Hum Pathol; 2015 May; 46(5):673-80. PubMed ID: 25704627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
    Nishikimi T; Tsuzuki T; Fujita T; Sassa N; Fukatsu A; Katsuno S; Yoshino Y; Hattori R; Gotoh M
    Pathol Int; 2011 Mar; 61(3):116-21. PubMed ID: 21355952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
    Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
    Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
    Chang BD; Cao LS; Zhou HL
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of peptidase activity on clear cell renal cell carcinoma survival.
    Larrinaga G; Blanco L; Sanz B; Perez I; Gil J; Unda M; Andrés L; Casis L; López JI
    Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1584-91. PubMed ID: 23019229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma.
    Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M
    Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
    Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
    Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
    BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression and clinical significance of TGF-beta1 and MMP2 in human renal clear cell carcinoma.
    Yang SD; Sun RC; Mu HJ; Xu ZQ; Zhou ZY
    Int J Surg Pathol; 2010 Apr; 18(2):85-93. PubMed ID: 19223381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.